Works matching IS 00316970 AND DT 2024 AND VI 80 AND IP 11

Results: 18

Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1829, doi. 10.1007/s00228-024-03752-z

By:

Resztak, Matylda;
Zalewska, Paulina;
Wachowiak, Jacek;
Sobkowiak-Sobierajska, Agnieszka;
Główka, Franciszek K.

Publication type:

Article

Therapeutic drug monitoring in tuberculosis.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1659, doi. 10.1007/s00228-024-03749-8

By:

Sarkar, M.;
Sarkar, J.

Publication type:

Article

Fixed parameters in the population pharmacokinetic modeling of valproic acid might not be suitable: external validation in Chinese adults with epilepsy or after neurosurgery.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1819, doi. 10.1007/s00228-024-03746-x

By:

Wu, Ruoyun;
Li, Kai;
Zhao, Zhigang;
Mei, Shenghui

Publication type:

Article

Prognostic effect of a vasopressin V<sub>2</sub> receptor antagonist in acute congestive heart failure patients with hypoperfusion, the wet–cold pattern.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1795, doi. 10.1007/s00228-024-03745-y

By:

Matsushita, Kenichi;
Harada, Kazumasa;
Miyamoto, Takamichi;
Iida, Kiyoshi;
Yamamoto, Yoshiya;
Shiraishi, Yasuyuki;
Nagatomo, Yuji;
Yoshino, Hideaki;
Yamamoto, Takeshi;
Nagao, Ken;
Takayama, Morimasa

Publication type:

Article

Evaluation of SLC6A2 and CYP2D6 polymorphisms' effects on atomoxetine treatment in attention deficit and hyperactivity disorder.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1773, doi. 10.1007/s00228-024-03744-z

By:

Kole, Ismail Hasan;
Vural, Pınar;
Yurdacan, Beste;
Alemdar, Adem;
Mutlu, Caner

Publication type:

Article

Model-informed dose optimization of mycophenolic acid in pediatric kidney transplant patients.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1761, doi. 10.1007/s00228-024-03743-0

By:

Heida, Astrid;
Jager, Nynke G. L.;
Aarnoutse, Rob E.;
de Winter, Brenda C. M.;
de Jong, Huib;
Keizer, Ron J.;
Cornelissen, Elisabeth A. M.;
ter Heine, Rob

Publication type:

Article

Therapeutic drug monitoring for valproate: deriving a novel formula for calculation of free concentration.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1751, doi. 10.1007/s00228-024-03741-2

By:

Pretorius, Erna;
van Zyl, Paulina;
Joubert, Gina

Publication type:

Article

Evaluation of pharmacokinetic target attainment and hematological toxicity of linezolid in pediatric patients.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1807, doi. 10.1007/s00228-024-03740-3

By:

Abouelkheir, Manal;
Aldawsari, Maram R.;
Ghonem, Leen;
Almomen, Aliyah;
Alsarhani, Emad;
Alsubaie, Sarah;
Alqahtani, Saeed;
Kurdee, Zeyad;
Alsultan, Abdullah

Publication type:

Article

Serious gaming as potential training tool for recognition of adverse drug reactions: side-effect exposure—medical education (SeeMe).

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1787, doi. 10.1007/s00228-024-03739-w

By:

Bergs, Ingmar;
Bell, Laura;
Fedrowitz, Sebastian;
Krüger, Tim;
Lemos, Martin;
Stingl, Julia C.;
Just, Katja S.

Publication type:

Article

Efficacy and safety of ramucirumab for gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1697, doi. 10.1007/s00228-024-03734-1

By:

Ren, Ruiqi;
Zhang, Zhewei;
Zhai, Shaokun;
Yang, Jiahui;
Tusong, BaihaiTihan;
Wang, Jingzhou

Publication type:

Article

Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1725, doi. 10.1007/s00228-024-03738-x

By:

B, Keerthanaa;
Appaji, Rashmi;
Thomas, Levin;
Baral, Tejaswini;
N, Skanda;
Chaithra;
M, Sonal Sekhar;
Saravu, Kavitha;
Undela, Krishna;
Rao, Mahadev

Publication type:

Article

Reference guides for the safe use of drugs during pregnancy: a systematic review and comparative analysis.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1625, doi. 10.1007/s00228-024-03736-z

By:

Jiao, Xue-Feng;
Qiu, Panda;
Song, Zheyun;
Peng, Xue;
Li, Hailong;
Zeng, Linan;
Zhang, Lingli

Publication type:

Article

Reliability and validity of the Turkish version of the medication practical barriers to adherence questionnaire in patients with chronic diseases.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1715, doi. 10.1007/s00228-024-03735-0

By:

Samuelyan, Nora;
Ay, Pınar;
Moon, Zoe;
Sancar, Mesut;
Horne, Rob;
Okuyan, Betul

Publication type:

Article

Drug administration via feeding tubes—a procedure that carries risks: systematic identification of critical factors based on commonly administered drugs in a cohort of stroke patients.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1599, doi. 10.1007/s00228-024-03723-4

By:

Sommerfeldt, Jana;
Sartorius, Hannes;
von Sarnowski, Bettina;
Klein, Sandra;
Ritter, Christoph A.

Publication type:

Article

Author's reply to the letter to the editor: "Effects of dapagliflozin and empagliflozin on 6‑min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta‑analysis of randomized controlled trials involving 2624 patients"

Published in:

2024

By:

Tanashat, Mohammad;
Manasrah, Almothana;
Abouzid, Mohamed

Publication type:

Letter

Short-term usage of proton pump inhibitors during admission was associated with increased risk of rehospitalization in critically ill patients with myocardial infarction: a cohort study.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1741, doi. 10.1007/s00228-024-03737-y

By:

Zhu, Jia-De;
Yang, Li-Juan;
Zhao, Jian-Nan;
Wang, Ping;
Li, Yi-Hua;
Zhang, Xue-Sha;
Pan, Jian-Mei;
Jiang, Meng-Han;
Yang, Hai-Ying;
Yin, Sun-Jun;
He, Gong-Hao

Publication type:

Article

Neuronal toxicity of monoclonal antibodies (mAbs): an analysis of post-marketing reports from FDA Adverse Event Reporting System (FAERS) safety database.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 11, p. 1685, doi. 10.1007/s00228-024-03727-0

By:

Kumar, Nitin;
Kalaiselvan, Vivekanandan;
Arora, Mandeep Kumar

Publication type:

Article

Letter to the editor: "Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials involving 2624 patients".

Published in:

2024

By:

Kotake, Kazumasa;
Adachi, Kazuki;
Nakano, Yuki

Publication type:

Letter to the Editor